NASDAQ: NEPH - Nephros, Inc.

Rentabilität für sechs Monate: -27.67%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Nephros, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Nephros, Inc.

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

weitere details
The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2004-09-21
ISIN US6406714005
Industry Household Durables
Sector Consumer Discretionary
Валюта usd
Валюта отчета usd
Сайт https://www.nephros.com
Цена ао 2.21
Preisänderung pro Tag: +0.6757% (1.48)
Preisänderung pro Woche: -3.25% (1.54)
Preisänderung pro Monat: -1.32% (1.51)
Preisänderung über 3 Monate: -12.87% (1.71)
Preisänderung über sechs Monate: -27.67% (2.06)
Preisänderung pro Jahr: -56.94% (3.46)
Preisänderung über 3 Jahre: -77.46% (6.61)
Preisänderung über 5 Jahre: -81.83% (8.2)
Preisänderung über 10 Jahre: 0% (1.49)
Preisänderung seit Jahresbeginn: -9.15% (1.64)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 2.25 6
P/BV 3.84 4
P/E 0 0
EV/EBITDA -21.48 0
Gesamt: 3.5

Effizienz

Name Bedeutung Grad
ROA, % -13.28 0
ROE, % -18.84 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -1.33 10
Gesamt: 9.4

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 38.23 5
Rentabilität Ebitda, % -56.91 0
Rentabilität EPS, % -64.02 0
Gesamt: 1
Weitere Details

Institutionen Volumen Aktie, %
Wexford Capital LP 3682724 48
Bard Associates Inc. 187318 2.44
Vanguard Group Inc 171310 2.23
Geode Capital Management, LLC 71037 0.93
HighTower Advisors, LLC 56710 0.74
Blair (William) & Company, L.L.C. 36249 0.47
Morgan Stanley 33774 0.44
Elkhorn Partners Limited Partnership 31900 0.42
State Street Corporation 15698 0.2
Mesirow Financial Investment Management, Inc. 15383 0.2

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
Dimensional U.S. Core Equity 2 ETF 0 30.76 1.47098



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Robert Banks President, CEO & Director 474.04k 1975 (50 Jahre)
Ms. Judy F. Krandel C.F.A. Chief Financial Officer 147.01k 1965 (60 Jahre)
Brianne McGuire Director of Brand, Marketing & Business Development N/A
Vashone R. Thomas Vice President of Quality, Regulatory, & Human Resources N/A
Mr. Greg Lucas President of Aether Water Systems N/A
Ms. Judy Mazzini Controller N/A
Mr. Alfred Vargas Director of Operations N/A
Mr. Daron G. Evans M.B.A., M.S. Chief Executive Officer of Specialty Renal Products, Inc 300.18k 1974 (51 Jahr)

Adresse: United States, South Orange. NJ, 380 Lackawanna Place - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.nephros.com